Development of icterus gravis in a preterm infant with G71R UGT1A1 polymorphism

被引:1
|
作者
Kaga A. [1 ,2 ]
Ohkubo Y. [1 ,2 ]
Watanabe Y. [1 ,2 ]
Saito S. [1 ]
Matsuki T. [1 ,2 ]
Usuda H. [1 ,2 ]
Kanda S. [1 ]
Suzuki Y. [1 ]
Tanabu M. [1 ]
Kure S. [2 ]
机构
[1] Department of Pediatrics, Hachinohe City Hospital, Hachinohe, Aomori, 031-8555
[2] Department of Pediatrics, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, 980-8574, 1-1, Seiryo-machi
关键词
G71R; Gilbert's syndrome; Icterus gravis; Preterm infant; Uridine diphosphate-glucuronosyltransferase;
D O I
10.1186/1756-0500-6-51
中图分类号
学科分类号
摘要
Background: Uridine diphosphate-glucuronosyltransferase (UGT) gene family is involved in the detoxification of biomaterials and drugs in the liver. Among the UGT gene family members, only UGT1A1 is involved in bilirubin conjugation. As a result, deficient UGT1A1 activity causes jaundice. One disease that is characterized by reduced UGT1A1 activity is Gilbert's syndrome. Two prevalent UGT1A1 polymorphisms responsible for Gilbert's syndrome have been identified: G71R in exon 1 and A(TA)7TAA in the TATA box of the promoter region. Recently, the G71R polymorphism has been associated with breastfeeding jaundice and neonatal hyperbilirubinemia in term infants. However, its association with jaundice in very low birth weight infants (VLBWIs) has never been reported. Case presentation. The patient was a female born at 28 weeks, 4 days gestation with a birth weight of 1172 g. On day 21, intense yellowing of the skin and eyes was noted, and the patient's total bilirubin level was 23.7 mg/dL (her direct bilirubin level was 2.1 mg/dL). Therefore, an exchange transfusion was conducted. She had neither blood type incompatibility nor a family history of constitutional jaundice. Metabolic screens for amino and organic acids were negative. No elevation of any of the examined antibody titers was noted, and no evidence of an inflammatory reaction was observed. In addition, no hematological abnormalities were detected. The direct/indirect Coombs test, irregular antibody test and red blood cell antibody dissociation test were all negative, and her thyroid function was normal. We performed sequence analysis of the UGT1A1 gene after the patient's parents provided written informed consent. Exon 1 of the UGT1 gene on chromosome 2 was analyzed by direct sequencing. A heterozygous substitution from G to A (211G→A: G71R) in base 211 was noted. Conclusion: We speculated that this preterm infant with carrying the G71R polymorphism reduced UGT1A1 activity and developed severe jaundice that was likely triggered by factors such as breast feeding and medications. The polymorphism appears at some frequency among VLBWIs, which would necessitate adequate care of severe jaundice even after the acute phase. © 2013 Kaga et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] G71R mutation of the UGT1A1 gene is not associated with neonatal hyperbilirubinemia in India
    D'Silva, Selma
    Colah, Roshan B.
    Ghosh, Kanjaksha
    Mukherjee, Malay B.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (09) : 1833 - 1834
  • [2] Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients
    Narter, Fatma
    Can, Gulay
    Ergen, Arzu
    Isbir, Turgay
    Ince, Zeynep
    Coban, Asuman
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 (02) : 313 - 316
  • [3] Frequency of G71R and Detection of a Novel Mutation in Exon 1 of the UGT1A1 Gene in a Malay Population
    Ma'amor, N. H.
    Yusoff, S.
    Zilfalil, Alwi B.
    Yusoff, Mohd N.
    Ramli, N.
    Ibrahim, N. R.
    Matsuo, M.
    Nishio, H.
    Van Rostenberghe, H.
    INTERNATIONAL MEDICAL JOURNAL, 2012, 19 (02): : 93 - 97
  • [4] Screening for G71R mutation of the UDP-glucuronosyltransferase 1 (UGT1A1) gene in neonates with pathologic and prolonged hyperbilirubinemia in Turkey
    Kilic, I.
    Koseler, A.
    Cakaloz, I.
    Atalay, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (08) : 504 - 508
  • [5] The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients
    AlFadhli, Suad
    Al-Jafer, Hassan
    Hadi, Mays
    Al-Mutairi, Mashael
    Nizam, Rasheeba
    PLOS ONE, 2013, 8 (10):
  • [6] Severe Neonatal Hyperbilirubinemia and UGT1A1 Promoter Polymorphism
    Travan, Laura
    Lega, Sara
    Crovella, Sergio
    Montico, Marcella
    Panontin, Elisa
    Demarini, Sergio
    JOURNAL OF PEDIATRICS, 2014, 165 (01) : 42 - 45
  • [7] UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
    Meza-Junco, Judith
    Chu, Quincy S. -C.
    Christensen, Olaf
    Rajagopalan, Prabhu
    Das, Soma
    Stefanyschyn, Ruslan
    Sawyer, Michael B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 1 - 4
  • [8] Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II
    Yamamoto, K
    Sato, H
    Fujiyama, Y
    Doida, Y
    Bamba, T
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1406 (03): : 267 - 273
  • [9] Correlation between UGT1A1 polymorphism and neonatal hyperbilirubinemia of neonates in Wuhan
    Wei Liu
    Li-wen Chang
    Min Xie
    Wen-bin Li
    Zhi-hui Rong
    Li Wu
    Ling Chen
    Current Medical Science, 2017, 37 : 740 - 743
  • [10] Preparation of reference material for UGT1A1 (TA)n polymorphism genotyping
    Mlakar, Vid
    Mlakar, Simona Jurkovic
    Marc, Janja
    Ostanek, Barbara
    CLINICA CHIMICA ACTA, 2014, 435 : 24 - 28